Siemens Healthineers AG Asset Resilience Ratio
Siemens Healthineers AG asset resilience ratio. Siemens Healthineers AG (SHL) has an Asset Resilience Ratio of 0.86% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Siemens Healthineers AG fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Siemens Healthineers AG (2017–2024)
Asset resilience ratio of Siemens Healthineers AG from 2017 to 2024. This chart shows how Siemens Healthineers AG's Asset Resilience Ratio has changed over time. Read SHL current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Siemens Healthineers AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SHL total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €393.00 Million | 0.86% |
| Total Liquid Assets | €393.00 Million | 0.86% |
Asset Resilience Insights
- Limited Liquidity: Siemens Healthineers AG maintains only 0.86% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Siemens Healthineers AG Industry Peers by Asset Resilience Ratio
Compare Siemens Healthineers AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
Siemens Healthineers AG Asset Resilience Ratio by Year (2017–2024)
Siemens Healthineers AG asset resilience ratio by year from 2017 to 2024. The table below shows the annual Asset Resilience Ratio data for Siemens Healthineers AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-09-30 | 0.50% | €229.00 Million ≈ $267.73 Million |
€46.05 Billion ≈ $53.84 Billion |
+0.23pp |
| 2023-09-30 | 0.27% | €124.00 Million ≈ $144.97 Million |
€46.68 Billion ≈ $54.58 Billion |
-0.06pp |
| 2022-09-30 | 0.33% | €162.00 Million ≈ $189.40 Million |
€49.06 Billion ≈ $57.35 Billion |
+0.14pp |
| 2021-09-30 | 0.19% | €79.00 Million ≈ $92.36 Million |
€42.16 Billion ≈ $49.29 Billion |
+0.06pp |
| 2020-09-30 | 0.12% | €31.00 Million ≈ $36.24 Million |
€25.09 Billion ≈ $29.34 Billion |
-0.01pp |
| 2019-09-30 | 0.13% | €28.00 Million ≈ $32.73 Million |
€21.43 Billion ≈ $25.05 Billion |
-0.01pp |
| 2018-09-30 | 0.14% | €28.00 Million ≈ $32.73 Million |
€19.76 Billion ≈ $23.10 Billion |
-0.14pp |
| 2017-09-30 | 0.28% | €57.00 Million ≈ $66.64 Million |
€20.44 Billion ≈ $23.90 Billion |
-- |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment… Read more